Daniel Nigh, a Benicar lawyer with the Levin, Papantonio law firm, is currently investigating the link between the use of the popular blood pressure medication Benicar (Olmesartan medoxomil) and the development of a rare gastrointestinal disease known as sprue-like enteropathy, resulting in the filing of Benicar lawsuits.
What is Benicar and Why is it Prescribed
Benicar is a blood pressure medication that blocks certain receptors, known as angiotensin receptors. Angiotensin II is a hormone that causes the blood vessels to constrict. By inhibiting the action of this hormone (as well as reducing the secretion and production of other hormones involved in regulating blood pressure), blood vessels become dilated.
Drugs of this class generate approximately $7 billion in revenue for the manufacturers. There are a number of angiotensin receptor blockers (ARBs) on the market, but only Benicar has been implicated in the development of the intestinal disorder known as sprue-like enteropathy. Often misdiagnosed as celiac disease, sprue-like enteropathy prevents the intestinal system from properly absorbing nutrients from food. In essence, a patient who is not treated for this condition literally starves to death.
What are the Side Effects, Complications and Risks of Benicar
A recent Mayo Clinic study, conducted by Dr. Josephy Murray, has linked the development of sprue-like enteropathy to the use of Benicar. Sprue-like enteropathy is a disease that produces severe gastrointestinal symptoms; such as chronic diarrhea, significant weight loss, nausea, and overall malnutrition.
Dr. Murray conducted the study on 22 patients who were using Benicar and experiencing gastrointestinal symptoms, initially diagnosed as Celiac disease. However, the patients in the study were not responding to a gluten-free diet, a common form of treatment for Celiac disease, and did not have detectable tissue transglutaminase in their blood, which is used to positively diagnose Celiac disease.
Upon discontinuation of Benicar, all 22 patients experienced relief from the gastrointestinal symptoms as well as weight gain. Dr. Murray concluded that the Benicar being taken by the patients was directly linked to the gastrointestinal symptoms the patients were experiencing. Dr. Murray’s study and findings on the link between Benicar use and sprue-like enteropathy was recently published online in the Mayo Clinic Proceedings, and began the process of Benicar lawyers filing Benicar Lawsuits.
In medical terms, Benicar may trigger an immune response. When receptors are blocked from responding to angiotensin II, this hormone continues to travel in the bloodstream. This, in turn, may induce the gene expression (a process by which genetic information is “released” and transformed into a protein, hormone or other biochemical) of “transformation growth factor” (TGF). This is a protein that can cause cellular mutation (one strain of this is implicated in the development of tumors). The increase in TGF may be responsible for the cellular damage in the intestinal tract leading to the symptoms of sprue-like enteropathy that Benicar patients suffer.
Has There Been a Recall of Benicar Resulting From Sprue-like Enteropathy
As of this time, a recall of Benicar related to sprue-like enteropathy has not occurred. However, there has been an FDA recommended label change detailing the relationship between Benicar and sprue-like enteropathy, as detailed below in the section "FDA and Scientific Studies Regarding Benicar."
Have there been any Significant Benicar Settlements
As of this time, there have been no large group settlements involving the Benicar litigation. Benicar lawsuits have just started to be filed, and our law firm was one of the very first in the country to file a Benicar lawsuit. We are actively pursuing the litigation in the discovery stage, and every day we are finding more troubling information regarding the correlation between Benicar and the rare gastrointestinal disease known as sprue-like enteropathy.
How Long Do I Have to File a Benicar Lawsuit
Every state has maximum time limitations on when an injury claim must be filed. These time restrictions are known as statutes of limitations. If a claim is not filed against the manufacturer, retailers and healthcare providers before the statute of limitation expires, the injured persons are forever prevented from bringing a claim against the entities and persons who may be liable for their injuries.
If you have been potentially injured by the use of Benicar, your statute of limitations may already have expired, or may expire in the very near future. Unfortunately, there is no way for us to tell you without us first reviewing the individual facts of your situation. The one thing we can absolutely state is that every day you wait to retain an attorney may be the last day you can bring a claim.
Free Confidential Consultation -- CLICK HERE
Why Should I Select Levin Papantonio to Handle my Benicar Case
Our law firm has been in existence since 1955, and is considered a national pioneer in this type of litigation. We are the founder of Mass Torts Made Perfect, which is a national seminar attended by approximately 600 lawyers twice per year where we help teach the successful discovery and trial techniques in national litigation against drug companies. In litigation such as this, federal judges often select a few attorneys to lead the pre-trial litigation for all those injured throughout the nation who have filed a federal lawsuit. To date, federal judges have selected our attorneys more than 35 times to serve in this capacity.
For a detailed discussion of our history, credentials, accomplishments and results, please visit our About Us section.
What Does It Cost to Hire Levin Papantonio
Our Benicar lawyers provide absolutely free confidential consultation, and if we are fortunate enough for you to hire us, we never will charge you any fees or costs unless you first recover.
The fee we charge ranges from 20% to 40% depending upon the amount we recover for you. This fee should be similar to, if not exactly the same, as to what other lawyers are charging. This is true whether your lawyer has never handled a prescription drug case or whether it has been the focus of their practice for more than 50 years, as with our law firm.
To contact us for a free confidential consult, you can call us at (850) 435-7000 (Pensacola) or (800) 277-1193 (toll free). You also can request a free private and confidential evaluation by clicking Free & Confidential Consult, and your inquiry will be immediately reviewed by one of our attorneys who handles your specific type case.
FDA and Scientific Studies Regarding Benicar
2013-07-03: FDA approves label changes to include intestinal problems (sprue-like enteropathy) linked to blood pressure medicine olmesartan medoxomil: The U.S. Food and Drug Administration (FDA) is warning that the blood pressure drug olmesartan medoxomil (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics) can cause intestinal problems known as sprue-like enteropathy. FDA has approved changes to the labels of these drugs to include this concern. To read more, click FDA Drug Safety Communication
Benicar Lawsuit News
Benicar Lawsuit News - Plaintiffs Attorneys Appointed: During a lull in the amount of product liability litigation in the country, two companies have the dubious honor of being the target of a growing number of lawsuits. Benicar maker Daiichi-Sankyo is one of them. According to statistics from the U.S. Judicial Panel on Multidistrict Litigation (JPML), the number of cases in recently-created MDLs for the Japanese-based drugmaker rose significantly between mid-April and mid-May of 2015. To read more, click Levin Law News
Benicar Lawsuit Plaintiff Lobbies for Ohio State Consolidation: All she wants for Christmas is justice served. Of course, Benicar side effects plaintiff Annette M. Johnson will have to wait, probably, a few Christmas seasons before she and other plaintiffs are in a position to unwrap their gift of compensation for Benicar illness and weight loss. Nonetheless, the process has begun, commencing with the filing of a Benicar defective products lawsuit in Ohio Northern District Court on December 5 (Johnson v. Daiichi Sankyo, Inc. et al, Case No. 3:2014cv02672, Ohio Northern District Court). The plaintiff is lobbying to have her lawsuit consolidated with others in Ohio State. To read more, click Lawyers and Settlements
Benicar Side Effects More Than Just a Pain in the Gut: The overall tally of Benicar lawsuits continues to creep slowly higher with the filing in late summer of a wrongful death lawsuit in New Jersey. The drug (olmesartan) is indicated to treat high blood pressure, a common malady amongst the American population. To read more, click Lawyers and Settlements
Illinois Couple Files Benicar Lawsuit: A Pawnee, Illinois couple has filed a Benicar diarrhea lawsuit, after the female plaintiff became severely ill as result of ingesting the blood pressure medication. Deborah Dirksen and her husband, Richard, allege the drug makers knew or should have known about the risk of enteropathy faced by patients taking Benicar, but failed to share this information with the public. To read more, click Injury-Lawyer News
Popular High Blood Pressure Drug Could Be Tip of the Litigation Iceberg: If there is one certainty about the pharmaceutical industry, it is that Big Pharma is never boring. And at the risk of appearing insensitive about the alleged harms from prescription medications suffered by innocent patients, the fact remains that Americans are hearing about an increasing number of long-approved drugs having seemingly new and unforeseen side effects that negatively impact a patient. Such is the case with Benicar, a drug indicated for hypertension and the lowering of high blood pressure. And to be sure, we are starting to see headlines that scream. To read more, click Lawyers and Settlements
Video--Daniel Nigh Discusses Benicar Lawsuit Claims Process, Facts and Issues
Transcript of Video: Daniel Nigh Discusses Benicar Lawsuit Claims Process, Facts and Issues